Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

• Main Authors: Milad Daneshi-Maskooni (Author), Seyed Ali Keshavarz (Author), Mostafa Qorbani (Author), Siavash Mansouri (Author), Seyed Moayed Alavian (Author), Mahtab Badri-Fariman (Author), Seyed Ali Jazayeri-Tehrani (Author), Gity Sotoudeh (Author)
• Format: Book
• Published: BMC, 2019-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Despite the reported health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no human research has studied its potency in non-alcoholic fatty liver disease (NAFLD) as the hepatic part of metabolic syndrome. Our aim was determining the effects of green...